Nitin Kumar, MD
Anesthesiology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Cep America - Anesthesia PC · G2 Anesthesia PC
Looking this up.
Hospitals listed: John Muir Medical Center - Concord Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kumar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A160293 · Current
Licensed to practise in California · since 2019 · expires 2027-01-31 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$48,490
Medicare paid this office $48,490 for 408 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Anesthesia for other procedure on large bowel using an endoscope | 184 | $20,235 | $110 |
| Anesthesia for exam of colon using an endoscope | 93 | $9,715 | $104 |
| Anesthesia for procedure on small and large bowel using an endoscope | 57 | $7,408 | $130 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 54 | $5,996 | $109 |
Who their Medicare patients are
408 Original Medicare patients in 2024. Average age 73 · Under 65 4% · 85 and older 4% · Women 56% · Also on Medicaid 14% · Health risk score 0.80. At or below the middle of the specialty; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 60% · Diabetes 20% · Coronary heart disease 17% · Cancer 14% · Chronic kidney disease 12% · Atrial fibrillation 11% · Depression 10% · COPD 8% · Heart failure 5% · Stroke 5%.
The office billed $680,264, Medicare allowed $57,171 and paid $48,490; for 412 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 408 | 412 | 73 | 0.80 | $680,264 | $48,490 |
| 2023 | 397 | 416 | 74 | 1.16 | $647,660 | $55,996 |
| 2022 | 383 | 421 | 73 | 1.01 | $843,050 | $60,986 |
| 2021 | 414 | 436 | 73 | 0.93 | $841,872 | $61,243 |
| 2020 | 254 | 286 | 75 | 1.75 | $760,379 | $53,955 |
| 2019 | 94 | 108 | 74 | 1.37 | $310,044 | $22,366 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Anesthesia for other procedure on large bowel using an endoscope | 129 | $14,250 | $110 |
| Anesthesia for procedure on small and large bowel using an endoscope | 67 | $8,418 | $126 |
| Anesthesia for exam of colon using an endoscope | 65 | $6,801 | $105 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 48 | $5,489 | $112 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $414 | $38 |
2022: 5 services
| Anesthesia for other procedure on large bowel using an endoscope | 116 | $14,840 | $128 |
| Anesthesia for procedure on small and large bowel using an endoscope | 52 | $7,202 | $139 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 56 | $6,535 | $117 |
| Anesthesia for exam of colon using an endoscope | 59 | $6,352 | $108 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $417 | $38 |
2021: 5 services
| Anesthesia for other procedure on large bowel using an endoscope | 155 | $20,840 | $134 |
| Anesthesia for procedure on small and large bowel using an endoscope | 61 | $8,720 | $143 |
| Anesthesia for exam of colon using an endoscope | 70 | $7,792 | $111 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 60 | $7,252 | $121 |
| Anesthesia for lens surgery | 13 | $1,818 | $140 |
2020: 4 services
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 34 | $4,717 | $135 |
| Anesthesia for other procedure on large bowel using an endoscope | 29 | $4,063 | $140 |
| Anesthesia for lens surgery | 25 | $3,797 | $146 |
| Anesthesia for procedure on small and large bowel using an endoscope | 12 | $1,922 | $160 |
Money from drug and device companies
$612 in 2025
| 2025 | 8 | 23 | None | $612 |
| 2024 | 9 | 19 | None | $486 |
| 2023 | 7 | 28 | None | $591 |
| 2022 | 2 | 7 | None | $139 |
| 2021 | 5 | 8 | None | $206 |
| 2020 | 2 | 4 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Entyvio | $213 | 9 payments
|
| Lilly USA | Omvoh | $197 | 6 payments
|
| Abbvie | Rinvoq | $82 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $30 | 1 payment
|
| Celltrion USA | Vegzelma | $28 | 1 payment
|
| Janssen Biotech | Tremfya | $23 | 1 payment
|
See all 23 published payments
| Abbvie | Meals · 2025-12-17 | Skyrizi | $31 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-13 | Entyvio | $32 |
| Celltrion USA | Meals · 2025-11-10 | Vegzelma | $28 |
| Abbvie | Meals · 2025-10-29 | Rinvoq | $23 |
| Abbvie | Meals · 2025-10-22 | Rinvoq | $28 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-16 | Entyvio | $23 |
| Ipsen Biopharmaceuticals | Meals · 2025-08-27 | Iqirvo | $16 |
| Lilly USA | Meals · 2025-08-15 | Omvoh | $25 |
| Ardelyx | Meals · 2025-08-08 | Ibsrela | $22 |
| Lilly USA | Meals · 2025-06-16 | Omvoh | $35 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-13 | Entyvio | $21 |
| Aimmune Therapeutics | Meals · 2025-06-09 | Zenpep | $30 |
| Lilly USA | Meals · 2025-06-06 | Omvoh | $35 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-28 | Entyvio | $12 |
| Lilly USA | Meals · 2025-04-21 | Omvoh | $34 |
| Janssen Biotech | Meals · 2025-04-14 | Tremfya | $23 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-28 | Entyvio | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-13 | Eohilia | $35 |
| Lilly USA | Meals · 2025-03-01 | Omvoh | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-25 | Entyvio | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-03 | Entyvio | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-31 | Entyvio | $22 |
| Lilly USA | Meals · 2025-01-30 | Omvoh | $35 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $486
| Janssen Biotech | Stelara | $128 | 3 payments
|
| Lilly USA | Omvoh | $120 | 4 payments
|
| Celltrion USA | Vegzelma | $76 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $53 | 3 payments
|
| Abbvie | Rinvoq | $26 | 1 payment
|
| Aimmune Therapeutics | Zenpep | $24 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $22 | 1 payment
|
| QOL Medical | Sucraid | $20 | 1 payment
|
| Braintree Laboratories | Suflave | $17 | 1 payment
|
2023: $591
| Janssen Biotech | Stelara | $183 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $183 | 9 payments
|
| QOL Medical | Sucraid | $80 | 4 payments
|
| Merck Sharp & Dohme | Dificid | $44 | 2 payments
|
| Abbvie | Rinvoq | $40 | 2 payments
|
| Boston Scientific | None | $37 | 2 payments
|
| Nestle Healthcare Nutrition | Zenpep | $25 | 1 payment
|
2022: $139
| Abbvie | Humira | $120 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $19 | 1 payment
|
2021: $206
| AbbVie | Humira | $100 | 4 payments
|
| Acacia Pharma | Barhemsys | $49 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $20 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $19 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $17 | 1 payment
|
2020: $142
| AbbVie | Humira | $83 | 3 payments
|
| Avanos Medical | On-Q* Pump and Accessories | $58 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 61.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033504642
- Licence
- CA A160293California A160293: Current · expires 2027-01-31
- Group
- Cep America - Anesthesia PC · G2 Anesthesia PC
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 100 N Academy Ave, Danville, PA, 17822
- NPI first listed
- 2015-03-31
- NPI last updated
- 2020-03-02
- NPI record certified
- 2020-03-02
This is when the NPI record was last certified, not a medical board exam.